{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:51:27Z","timestamp":1767847887596,"version":"3.49.0"},"reference-count":66,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The National Swedish Research Council for Working Life and Social Sciences","award":["2009-1724"],"award-info":[{"award-number":["2009-1724"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Opioid use disorders (OUD) is a relapsing condition with high mortality. Opioid maintenance treatment (OMT) reduces heroin use, and overall morbidity and mortality. The prevalence of psychiatric and substance use disorders, potential baseline predictors for psychiatric hospitalization, and psychiatric diagnoses at follow-up were investigated and may give hints about possible preventative strategies. The medical records for 71 patients were reviewed 36 months following referral to OMT from a needle exchange program (NEP). Their psychiatric diagnoses and hospitalizations were identified. Their baseline characteristics were assessed for potential differences between hospitalized versus non-hospitalized patients and between patients with and without psychiatric diagnoses in a longitudinal observational study without controls. A regression analysis was performed to identify predictors for hospitalization when controlling for OMT status. Sixty-five percent of the patients were hospitalized at least once with a psychiatric diagnosis. Substance-related reasons were prevalent, and detoxification occurred among 59% of patients, with sedative- hypnotics (benzodiazepines, zopiclone, zolpidem, and pregabalin) being the substance used by 52% of patients. Baseline use of these drugs and\/or buprenorphine predicted for hospitalization when controlling for OMT status. During the follow-up period, 72% of patients met the criteria for a psychiatric diagnosis other than OUD. The prevalence of non-substance use disorders overlapping with SUD was 41%, and that overlapping with anxiety disorder was 27% of all participants. Increased attention to psychiatric co-occurring disorders in the treatment of OUD is required and the importance of addressing sedative-hypnotics use when initiating OMT is highlighted.<\/jats:p>","DOI":"10.3390\/ijerph19020697","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T20:29:26Z","timestamp":1641760166000},"page":"697","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Substance Use, Hospitalizations, and Co-Occurring Disorders among Patients Transferred from a Needle Exchange Program to Opioid Maintenance Treatment"],"prefix":"10.3390","volume":"19","author":[{"given":"Martin","family":"Br\u00e5b\u00e4ck","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences Lund, Faculty of Medicine, Division of Psychiatry, Lund University, SE222 41 Lund, Sweden"},{"name":"Addiction Center Malm\u00f6, Division of Psychiatry, Lund University, SE222 41 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Brantefors","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Faculty of Medicine, Division of Psychiatry, Lund University, SE222 41 Lund, Sweden"},{"name":"Addiction Center Malm\u00f6, Division of Psychiatry, Lund University, SE222 41 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Franck","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, SE171 77 Solna, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Br\u00e5dvik","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Faculty of Medicine, Division of Psychiatry, Lund University, SE222 41 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernilla","family":"Isendahl","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital Sk\u00e5ne, SE205 02 Malm\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzan","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Addiction Center Malm\u00f6, Division of Psychiatry, Lund University, SE222 41 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Troberg","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Faculty of Medicine, Division of Psychiatry, Lund University, SE222 41 Lund, Sweden"},{"name":"Addiction Center Malm\u00f6, Division of Psychiatry, Lund University, SE222 41 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5800-8975","authenticated-orcid":false,"given":"Anders","family":"H\u00e5kansson","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Faculty of Medicine, Division of Psychiatry, Lund University, SE222 41 Lund, Sweden"},{"name":"Addiction Center Malm\u00f6, Division of Psychiatry, Lund University, SE222 41 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","article-title":"33-year follow-up of narcotics addicts","volume":"58","author":"Hser","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: Harms to populations, interventions, and future action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"key":"ref_3","unstructured":"(2021, September 29). Opioid Maintenance Treatment\u2014A Call for a Joint European Quality Care Approach. Available online: https:\/\/www.karger.com\/article\/Abstract\/432395."},{"key":"ref_4","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","article-title":"Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain","volume":"100","author":"Brugal","year":"2005","journal-title":"Addiction"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"ref_8","first-page":"347","article-title":"Methadone maintenance treatment (MMT): A review of historical and clinical issues","volume":"67","author":"Joseph","year":"2000","journal-title":"Mt. Sinai J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance Medication for Opiate Addiction: The Foundation of Recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J. Addict. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archpsyc.64.5.566","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions","volume":"64","author":"Compton","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2005.11.025","article-title":"Psychiatric comorbidity in young heroin users","volume":"84","author":"Brugal","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0376-8716(00)00148-4","article-title":"The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients","volume":"61","author":"Cacciola","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: A review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1521-0391.2009.00007.x","article-title":"Benzodiazepines, Methadone and Buprenorphine: Interactions and Clinical Management","volume":"19","author":"Lintzeris","year":"2010","journal-title":"Am. J. Addict."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/hup.1222","article-title":"Longitudinal patterns of benzodiazepine consumption in a German cohort of methadone maintenance treatment patients","volume":"26","author":"Specka","year":"2011","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: A systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10550880802122620","article-title":"The Impact of Benzodiazepine Use on Methadone Maintenance Treatment Outcomes","volume":"27","author":"Brands","year":"2008","journal-title":"J. Addict. Dis."},{"key":"ref_18","first-page":"104","article-title":"Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: Characteristics and a pharmacotherapeutic approach","volume":"39","author":"Bleich","year":"2002","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"ref_19","first-page":"1765","article-title":"Fatal heroin \u2018overdose\u2019: A review","volume":"91","author":"Darke","year":"1996","journal-title":"Addiction"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","article-title":"Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study","volume":"174","author":"Abrahamsson","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers","volume":"54","author":"Brooner","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000274177","article-title":"Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment","volume":"43","author":"Verthein","year":"2010","journal-title":"Psychopathology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/10550490802019725","article-title":"Personality disorder features as predictors of symptoms five years post-treatment","volume":"17","author":"Jansson","year":"2008","journal-title":"Am. J. Addict."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1176\/appi.ajp.160.5.890","article-title":"The role of psychiatric disorders in predicting drug dependence treatment outcomes","volume":"160","author":"Compton","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archpsyc.1983.04390010030004","article-title":"Predicting response to alcohol and drug abuse treatments: Role of psychiatric severity","volume":"40","author":"McLellan","year":"1983","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00005053-200109000-00004","article-title":"Influence of antisocial personality subtypes on drug abuse treatment response","volume":"189","author":"King","year":"2001","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000321465","article-title":"Effect of psychiatric severity on the outcome of methadone maintenance treatment","volume":"17","author":"Pani","year":"2011","journal-title":"Eur. Addict. Res."},{"key":"ref_28","first-page":"126","article-title":"Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic","volume":"43","author":"Gelkopf","year":"2006","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2147\/NDT.S129480","article-title":"The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: A prospective cohort study","volume":"13","author":"Rosic","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.3390\/ijerph6112822","article-title":"Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: An 18-month follow-up study","volume":"6","author":"Astals","year":"2009","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/0269881110364266","article-title":"Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance","volume":"25","author":"Ngo","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.biopsych.2004.06.037","article-title":"Treatment of depression in patients with opiate dependence","volume":"15","author":"Nunes","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/bmj.38296.611215.AE","article-title":"Reinstitutionalisation in mental health care: Comparison of data on service provision from six European countries","volume":"330","author":"Priebe","year":"2005","journal-title":"BMJ"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1192\/bjp.bp.110.085100","article-title":"Outcomes of Nordic mental health systems: Life expectancy of patients with mental disorders","volume":"199","author":"Wahlbeck","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0022042615575374","article-title":"Predictors of Psychiatric Hospitalization in Ex-Prisoners With Substance Use Problems: A Data-Linkage Study","volume":"45","author":"Olsson","year":"2015","journal-title":"J. Drug Issues"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/add.13249","article-title":"Malm\u00f6 Treatment Referral and Intervention Study (MATRIS)\u2014effective referral from syringe exchange to treatment for heroin dependence: A pilot randomized controlled trial","volume":"111","author":"Nilsson","year":"2016","journal-title":"Addiction"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: Lowering the treatment thresholds","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fpsyt.2017.00161","article-title":"Malm\u00f6 Treatment Referral and Intervention Study\u2014High 12-Month Retention Rates in Patients Referred from Syringe Exchange to Methadone or Buprenorphine\/Naloxone Treatment","volume":"8","author":"Troberg","year":"2017","journal-title":"Front. Psychiatry"},{"key":"ref_39","unstructured":"(Socialstyrelsen) TNBoHaW (2016). Socialstyrelsens f\u00f6reskrifter och allm\u00e4nna r\u00e5d om l\u00e4kemedelsassisterad behandling vid opioidberoende [The Board\u2019s provisions and general guidelines on medication-assisted treatment in opiate dependence]. HSLF-FS, 1, 1\u20136."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/j.1360-0443.2010.02999.x","article-title":"Were the changes to Sweden\u2019s maintenance treatment policy 2000\u201306 related to changes in opiate-related mortality and morbidity?","volume":"105","author":"Engdahl","year":"2010","journal-title":"Addiction"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The Fifth Edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4155\/fmc.10.178","article-title":"Insights into the structure and pharmacology of GABA(A) receptors","volume":"2","author":"Carter","year":"2010","journal-title":"Future Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40265-020-01432-7","article-title":"Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update","volume":"81","author":"Evoy","year":"2020","journal-title":"Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.addbeh.2013.05.008","article-title":"Treatment or \u201chigh\u201d: Benzodiazepine use in patients on injectable heroin or oral opioids","volume":"38","author":"Vogel","year":"2013","journal-title":"Addict. Behav."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0376-8716(93)90090-D","article-title":"Benzodiazepine and sedative use\/abuse by methadone maintenance clients","volume":"32","author":"Iguchi","year":"1993","journal-title":"Drug Alcohol Depend."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1037\/1064-1297.9.1.40","article-title":"Human methadone self-administration: Effects of diazepam pretreatment","volume":"9","author":"Spiga","year":"2001","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1360-0443.2001.96811135.x","article-title":"Heroin overdose: Causes and consequences","volume":"96","author":"Darke","year":"2001","journal-title":"Addiction"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our Other Prescription Drug Problem","volume":"378","author":"Lembke","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited-will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jsat.2009.03.006","article-title":"Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients","volume":"37","author":"Lavie","year":"2009","journal-title":"J. Subst. Abuse. Treat."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/15622970802176487","article-title":"Psychiatric co-occurring disorders and additional abuse of drugs in maintenance treatment with L- and D,L-methadone","volume":"11","author":"Wedekind","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"9298571","DOI":"10.1155\/2016\/9298571","article-title":"Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence","volume":"2016","author":"Dahlman","year":"2016","journal-title":"J. Addict."},{"key":"#cr-split#-ref_53.1","doi-asserted-by":"crossref","unstructured":"Vold, J.H., Skurtveit, S., Aas, C., Chalabianloo, F., Kloster, P.S., Johansson, K.A., and Fadnes, L.T. (2020). Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy","DOI":"10.1186\/s12913-020-05195-5"},{"key":"#cr-split#-ref_53.2","unstructured":"a prospective cohort study in Norway from 2013 to 2017. BMC Health Serv. Res., 25."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e036860","DOI":"10.1136\/bmjopen-2020-036860","article-title":"Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: A register-based prospective cohort study in Norway and Sweden from 2015 to 2017","volume":"10","author":"Vold","year":"2020","journal-title":"BMJ Open"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jad.2006.09.017","article-title":"Depression in methadone maintenance treatment patients: Rate and risk factors","volume":"99","author":"Peles","year":"2007","journal-title":"J. Affect. Disord."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.drugalcdep.2010.06.013","article-title":"Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: Findings of the German randomized controlled trial","volume":"112","author":"Haasen","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/11536020-000000000-00000","article-title":"Intravenous misuse of buprenorphine: Characteristics and extent among patients undergoing drug maintenance therapy","volume":"30","author":"Moratti","year":"2010","journal-title":"Clin. Drug Investig."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.drugalcdep.2015.01.028","article-title":"Profiles of psychiatric disorders among heroin dependent individuals in Changsha, China","volume":"149","author":"Yang","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"ref_59","first-page":"6487217","article-title":"Correlates of Nine-Month Retention following Interim Buprenorphine-Naloxone Treatment in Opioid Dependence: A Pilot Study","volume":"2016","author":"Widinghoff","year":"2016","journal-title":"J. Addict."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12954-017-0134-5","article-title":"The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario","volume":"14","author":"Franklyn","year":"2017","journal-title":"Harm Reduct. J."},{"key":"ref_61","first-page":"285","article-title":"Benzodiazepine usage during 19.5 years in methadone maintenance treatment patients and its relation to long-term outcome","volume":"51","author":"Peles","year":"2014","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4088\/JCP.v63n0715","article-title":"Sex differences in depressed substance abusers","volume":"63","author":"Sinha","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cpp.693","article-title":"Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II)","volume":"18","author":"Lobbestael","year":"2011","journal-title":"Clin. Psychol. Psychother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.drugalcdep.2003.11.014","article-title":"Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program","volume":"74","author":"Kidorf","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugalcdep.2008.03.026","article-title":"A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals","volume":"97","author":"Neufeld","year":"2008","journal-title":"Drug Alcohol Depend."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/2\/697\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:01:44Z","timestamp":1760364104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/2\/697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":66,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijerph19020697"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19020697","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]}}}